FDA Announces Proposed Collection of Information for Review by OMB

Summary

The Food and Drug Administration (FDA) is submitting a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its efforts to improve the submission of pharmacogenomic data.